Comparison of endoscopic healing and durability between infliximab originator and CT-P13 in pediatric patients with inflammatory bowel disease.
Kim ES, Choi S, Choe BH, Park S, Lee YJ, Sohn SJ, Kim SC, Kang KS, Lee K, Shim JO, Kim YB, Hong SJ, Lee YM, Kim HJ, Choi SY, Kim JY, Lee Y, Park JS, Kim JY, Yi DY, Lee JH, Choi KH, Jang HJ, Jeong IS, Kang B.
Kim ES, et al. Among authors: shim jo.
Front Immunol. 2024 Feb 22;15:1284181. doi: 10.3389/fimmu.2024.1284181. eCollection 2024.
Front Immunol. 2024.
PMID: 38455036
Free PMC article.